$100 billion market cap is the blue-sky scenario for Moderna, analyst says
February 25, 2021 at 09:30 AM EST
Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to an analyst.
